Mortality rates per lifecycle stage [28]. by Albertus Constantijn Sloof (20405090)

Changes in mortality and DALYs per100,000 rates by cancer types from 1990 to 2019 in Iran; a) Mortality rate; b) DALYs per100000 rate. by Mitra Darbandi (17967619)

Subjects:

Distribution of age-standardized total cancer in the provinces of Iran, 1990 and 2019. a) Mortality rate in 1990; b) Mortality rate in 2019; c) DALY rate in 1990; d) DALY rate in 2... by Mitra Darbandi (17967619)

Subjects:

Birth rate and population. by Jennifer Astley (19859612)

Subjects:

Changes in the monthly contamination rate (per set) in blood culture (BC). by Miki Doi (15347878)

Ranking of age-standardized mortality rates and DALY in each province of Iran for cancers, 2019. a) Mortality rate; b) DALY. by Mitra Darbandi (17967619)

Subjects:

The age-standardized trends of all cancers in Iran. a) The Mortality Rate; b) DALYs per100000 rate between 1990 and 2019 in Iran. by Mitra Darbandi (17967619)

Subjects:

National (A) Medicare prescription rates per thousand Part D enrollees and (B) Medicare spending for clozapine gradually decreased for 2015-2020. by Luke R. Cavanah (19022435)

“…<p>National (A) Medicare prescription rates per thousand Part D enrollees and (B) Medicare spending for clozapine gradually decreased for 2015-2020.…”

Crude and age-specific incidence rates (A), all-cause mortality rates (B), and prevalence rates (C) of liver cancer per 100,000 over 2014–2023. by Ayana Ablayeva (22103708)

Subjects:

Crude and type-specific incidence rates (A), all-cause mortality rates (B), and prevalence rates (C) of liver cancer per 100,000 over 2014–2023. by Ayana Ablayeva (22103708)

Subjects:

Crude and residence-specific incidence rates (A), all-cause mortality rates (B), and prevalence rates (C) of liver cancer per 100,000 over 2014–2023. by Ayana Ablayeva (22103708)

Subjects:

Comparison of the albendazole and ivermectin parasitological cure rate (Per-protocol). by Luccheri Ndong Akomezoghe (18585684)

Percent of change for mortality and DALYs per100000 rates by cancers in Iran (1990 to 2019). by Mitra Darbandi (17967619)

Subjects:

The crude incidence rates of NPC and ENKTL. by Shyh-An Yeh (10011348)

Subjects:

Effect of feed rate per tooth on residual stress in alumina ceramics. by Zhen Wang (72451)

Trends in childhood meningitis incidence rates(A) and death rates(B) by SDI regions, 1990-2021. by Jun Li (6494)

Subjects:

Mortality rate for different types of cancers in Iran, 2019, a) Men; b) Women. by Mitra Darbandi (17967619)

Subjects:

The age-standardized incidence rates of NPC and ENKTL. by Shyh-An Yeh (10011348)

Subjects:

Difference between estimated taxonomic effort and actual number of species described per period and per family. Abbreviations: Increased = I; Stable = S; Decreased = D. by Janaína Gomes-da-Silva (7852157)

Effect of feed rate per tooth on the maximum surface temperature of alumina bioceramics. by Zhen Wang (72451)